-
Reactive Oxygen Species Assay Kit: Advanced DHE Probe Workfl
2026-04-22
The APExBIO Reactive Oxygen Species Assay Kit (DHE) offers robust, quantitative detection of intracellular superoxide, transforming oxidative stress and apoptosis research. Its validated dihydroethidium probe workflow integrates seamlessly into redox signaling studies, delivering reproducible and actionable data.
-
PCMT1 Drives Ovarian Cancer Metastasis: CRISPR Screen Insigh
2026-04-21
Zhang et al. (2022) systematically identified PCMT1 as a key regulator of anoikis resistance and metastatic progression in ovarian cancer using a genome-wide CRISPR/Cas9 screen. Their findings highlight PCMT1’s role in ECM interaction and FAK-Src signaling, suggesting new therapeutic targets for metastatic disease.
-
V5 Epitope Tag Peptide: Optimizing Protein Tagging Workflows
2026-04-21
The V5 Epitope Tag Peptide streamlines protein detection and purification by enabling high-specificity, multiplexed assays. This article translates advanced single-molecule antibody screening and practical troubleshooting into actionable guidance for efficient recombinant protein workflows.
-
Acifran: Structural Insights for Precision Lipid Metabolism
2026-04-20
Explore how Acifran, a selective (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid agonist, uniquely enables advanced lipid metabolism research. This article reveals cutting-edge structural and functional evidence for optimizing metabolic disorder assays.
-
Spatiotemporal Hippo Signaling Modules Direct Liver Cell Fat
2026-04-20
This study dissects how two distinct Hippo signaling modules, HPO1 and HPO2, act at specific times and locations to regulate hepatocyte and cholangiocyte maturation in mouse liver development. By integrating spatial transcriptomics and imaging, the work reveals critical checkpoints in liver cell fate decisions, with implications for understanding tissue regeneration and disease.
-
Bafilomycin A1: Precision V-ATPase Inhibitor for Lysosomal R
2026-04-19
Bafilomycin A1 from APExBIO enables highly selective, nanomolar-range inhibition of vacuolar H+-ATPases, unlocking reproducible workflows for probing lysosomal function, intracellular pH, and disease mechanisms. This article translates literature-backed protocols and troubleshooting tips into actionable strategies for robust, interpretable assays.
-
Technical Guide: EdU Flow Cytometry Assay Kits (Cy5) Workflo
2026-04-18
EdU Flow Cytometry Assay Kits (Cy5) address the need for sensitive, reproducible detection of cell proliferation by enabling direct S-phase DNA synthesis measurement without harsh DNA denaturation. This kit is best suited for flow cytometry-based cell cycle studies and is not intended for applications outside DNA synthesis detection or incompatible with copper-catalyzed chemistry.
-
TNF-alpha Recombinant Murine Protein: Applied Workflows & In
2026-04-17
Harness the precision of TNF-alpha recombinant murine protein for dissecting apoptosis and inflammation in translational models. This guide details evidence-driven workflows, advanced applications, and troubleshooting tactics, integrating the latest mechanistic insights from RNA Pol II research.
-
Sulfo-NHS-SS-Biotin: Precision Protein Labeling for Purifica
2026-04-16
Sulfo-NHS-SS-Biotin stands apart as a water-soluble, cleavable biotin disulfide N-hydroxysulfosuccinimide ester for highly specific, reversible protein labeling. Its unique workflow flexibility and membrane-impermeant design empower advanced affinity purification and cell surface proteomics, offering clear advantages for researchers seeking dynamic and robust bioconjugation strategies.
-
AP20187: Chemical Inducer of Dimerization in Advanced Assays
2026-04-15
AP20187 delivers unmatched precision as a chemical inducer of dimerization, enabling regulated control of protein interactions and gene expression in both in vitro and in vivo models. Its validated solubility and reproducibility set a benchmark for fusion protein dimerization and conditional gene therapy activator workflows.
-
Selective β-Blockade Preserves Hematopoietic Regeneration Po
2026-04-14
This study demonstrates that nonselective β-adrenergic blockers impair hematopoietic regeneration following hematopoietic cell transplantation (HCT) in mice and humans, whereas β1-selective inhibition does not. These findings highlight a crucial distinction in β-blocker pharmacology for post-HCT care and inform selection strategies for clinical and experimental protocols.
-
Refining In Vitro Drug Response Metrics in Cancer Research
2026-04-13
Schwartz (2022) presents a nuanced investigation into how in vitro drug response metrics—specifically, relative viability and fractional viability—differ in their measurement of anti-cancer drug effects. This work clarifies the distinct biological information each metric provides, with practical implications for more accurate assessment of agents like chlorambucil in cancer pharmacology.
-
ATRA Overcomes PARP Inhibitor Resistance in Cisplatin-Treate
2026-04-13
This study demonstrates that all-trans retinoic acid (ATRA) can resensitize epithelial ovarian cancer (EOC) cells, rendered resistant to PARP inhibition by prior cisplatin exposure, to subsequent PARP inhibitor therapy. The findings highlight a promising combination maintenance strategy to address PARP inhibitor resistance in EOC.
-
Cholesterol Impedes Lipid Nanoparticle Trafficking for Cargo
2026-04-12
This study demonstrates that increased cholesterol content in lipid nanoparticles (LNPs) disrupts their intracellular trafficking, leading to reduced efficiency in nucleic acid delivery. The findings challenge assumptions about cholesterol's purely beneficial role in LNP formulations, offering mechanistic insights to guide optimization of delivery systems.
-
Tolazoline as an α2-Adrenergic Receptor Antagonist: Laborato
2026-04-12
Tolazoline’s dual action as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker empowers researchers to dissect both neurogenic and metabolic pathways in vitro. This article maps out advanced workflows, protocol parameters, and troubleshooting strategies that maximize Tolazoline’s value in islet function and airway smooth muscle assays.